HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Mahmoud Loubani Sudip Ghosh Manuel Galiñanes Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Loubani, M. Articles by Galiñanes, M. Search for Related Content PubMed PubMed Citation Articles by Loubani, M. Articles by Galiñanes, M. Related Collections Myocardial protection

J Thorac Cardiovasc Surg 2003;126:143-147
© 2003 The American Association for Thoracic Surgery

Cardiopulmonary support and physiology

The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning

^a Department of Integrative Human Cardiovascular Physiology and Cardiac Surgery, University of Leicester, Glenfield Hospital, Leicester, United Kingdom

Received for publication Jan 3, 2002 Received for publication April 30, 2002; revisions received August 17, 2002; accepted for publication August 22, 2002.

^* Address for reprints: Professor Manuel Galiñanes, Department of Integrative Human Cardiovascular Physiology and Cardiac Surgery, University of Leicester, Glenfield Hospital, Leicester LE3 9QP, UK
mg50{at}le.ac.uk

BACKGROUND: Increasing age has been recognized as a cause for adverse prognosis in the setting of myocardial infarction, coronary angioplasty, and cardiac surgery. This is attributed to a greater susceptibility of the senescent heart to ischemic injury and to a lower response to protective interventions. This study investigated the effect of aging on the tolerance to ischemia of the human myocardium and its response to ischemic preconditioning.

METHODS: Right atrial specimens from 128 patients undergoing elective heart surgery were collected, sliced, and equilibrated for 30 minutes before being randomized into 3 study protocols: (1) 210 minutes of aerobic incubation (time-matched control), (2) 90 minutes of simulated ischemia and 120 minutes of reoxygenation, and (3) ischemic preconditioning with 5 minutes of ischemia and 5 minutes of reoxygenation before 90 minutes of ischemia and 120 minutes of reoxygenation. Patients were subdivided into 3 age groups: 30 to 49 years, 50 to 69 years, and 70 to 90 years. At the end of each protocol, tissue injury and viability were assessed by the leakage of creatine kinase and the reduction of 3-(4,5 dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide to insoluble formazan dye.

RESULTS: There were no differences among the 3 groups of patients in their comorbid conditions or their cardiac medications. Ischemic injury was similar in all 3 groups (creatine kinase = 4.1 ± 0.7, 3.6 ± 1.0, and 4.3 ± 1.1 U/g wet weight, respectively; 3-(4,5 dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide = 64.7 ± 31.3, 96.3 ± 32.0, and 61.0 ± 30.4 mM/g wet weight, respectively, P = not significant in all cases), and ischemic preconditioning equally protected against ischemia at all ages (creatine kinase = 1.9 ± 0.5, 1.8 ± 0.4, and 2.1 ± 0.6 U/g wet weight, respectively; 3-(4,5 dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide = 157.9 ± 31.5, 170.7 ± 35.3, and 138.4 ± 43.8 mM/g wet weight, respectively; P < .05 in all cases vs ischemia alone).

CONCLUSION: Age does not influence the tolerance of the human myocardium to ischemia or the protective effect of ischemic preconditioning. These results indicate the need for a reevaluation of the importance of age in risk scoring in cardiac surgery.